Altogether, our data demonstrate for the first time the requirement of A2AR in fat tissues in the regulation of metabolic homeostasis and suggest the possibility of developing fat tissue–selective A2AR agonists for therapeutic use to combat obesity and associated metabolic dysfunction. The gene discussed is ADORA2A; the disease is Obesity.